• LAST PRICE
    0.0001
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0001
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIYXI
Inyx Inc
5.3K
0.0x
---
United StatesINBP
Integrated Biopharma Inc
10.5M
3.4x
+3.74%
United StatesHCLC
Health-Chem Corp
1.2K
0.0x
---
United StatesAQST
Aquestive Therapeutics Inc
46.6M
-0.5x
---
United StatesSUWN
Sunwin Stevia International Inc
1.2M
-0.8x
---
United StatesCHME
China Medicine Corp
78.0K
0.0x
---
As of 2023-02-04

Company Information

Inyx, Inc. is a provider of specialty pharmaceutical products and technologies. Its operations are focused on the development of both prescriptions, over the counter pharmaceutical products, and specialty consulting services. Also, the Company utilizes niche drug delivery capabilities to develop its own products. The product and service categories of the Company include Metered Dose Inhalers (MDIs) (CFC & HFA), Dry Powder Inhalers (DPIs), Metered Dose Pump Sprays (nasal and oral), Hydrocarbon Foam Aerosols, Saline Aerosols, Sterile Solutions/Injectables, Solid Dose, Formulation Services, Analytical Development Validation, Stability Services, Regulatory Support and Integrated Project Management.

Contact Information

Headquarters
825 3rd Ave Fl 40NEW YORK, NY, United States 10022-7592
Phone
212-838-1111
Fax
212-838-0060

Executives

Chairman of the Board, Chief Executive Officer
Jack Kachkar
President
Steven Handley
Executive Vice President, Chief Scientific Officer
Colin Hunter
Executive Vice President and Director of Corporate Development, Director
Jay Green
Vice President of Sales and Marketing and Commercial Development
Stephen Beckman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.3K
Revenue (TTM)
$85.0M
Shares Outstanding
53.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.16
EPS
$-0.79
Book Value
$-0.70
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-31.30%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.